Nissan Chemical Corporation (4021.T) Stock

Basic Materials · Chemicals · Member of Nikkei 225

Nissan Chemical Corporation (4021.T) closed at JPY 8,609.00 on 2026-10-15, a change of +69.4 % over the past year, with a market capitalization of JPY 1.14T.

Nissan Chemical Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Nissan Chemical Corporation key figures

Previous close

JPY 8,609.00 (2026-10-15)

1-year change

+69.4 %

Market cap

JPY 1.14T

Enterprise value

JPY 1.16T

P/E ratio (trailing)

23.35

P/E ratio (forward)

26.48

EPS (trailing)

365.68

EPS (forward)

322.46

PEG ratio

0.67

Price to book

4.54

Revenue growth

12.8 %

Earnings growth

23 %

Dividend per share (trailing)

202.00

Short ratio

n/a

Employees

3,411

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Nissan Chemical Corporation

Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and healthcare businesses in Japan and internationally. It provides high purity and custom chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid, as well as concrete and construction-related products; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; TEPIC-VL, a liquid epoxy compound; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; FINEOXOCOL, a saturated fatty alcohol and acid; Melamine particles, a spherical fine particles; STARFINE, a Triazine based adhesion; melamine polyphosphate; and NFG, a highly functional additive. The company also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, it provides pharmaceutical products, such as LIVALO, a drug for treating hypercholesterolemia; LANDEL and FINTE, a long-acting calcium channel blocker; and develops NTC-801, a pharmacological for treatment of arrhythmia. Further, it develops life science, information and communication, and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Chuo, Japan.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Nissan Chemical Corporation and compare it with other stocks.